NMNathan L. Maassel

Nathan L. Maassel

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nathan L. Maassel has a total of 52 co-authors. Here are the top co-authors by number of shared publications:

  • Daniel G. Solomon

    Division of Pediatric Surgery, Department of Surgery, Yale School of Medicine, New Haven, Connecticut

    3 shared publications
  • David H. Stitelman

    Department of Surgery, Yale University School of Medicine, New Haven, CT, USA

    3 shared publications
  • Andrea G. Asnes

    Department of Pediatrics, Yale School of Medicine, New Haven, Connecticut

    2 shared publications
  • Daniel G. Solomon

    Yale New Haven Children's Hospital, Division of Pediatric Surgery, New Haven, CT, USA

    2 shared publications
  • David Stitelman

    Department of Surgery, Division of Pediatric Surgery, Yale University School of Medicine, New Haven, USA

    2 shared publications
  • John M. Leventhal

    Department of Pediatrics, Yale School of Medicine, New Haven, Connecticut

    2 shared publications

Latest Publications

  • Open Access

    Hospital Admissions for Abusive Head Trauma Before and During the COVID-19 Pandemic

    by Nathan L. Maassel, Elena Graetz, Eric B. Schneider, Andrea G. Asnes, Daniel G. Solomon, John M. Leventhal

    Importance: Several studies have demonstrated a decrease in the occurrence of child abuse in the US since the start of the COVID-19 pandemic. This finding has generated concern for missed cases due to the initial lockdowns and lack of childcare resources. Determining the association of the pandemic on hospitalizations for severe forms of abuse is essential to focus preventive efforts.Objective: To examine trends in abusive head trauma (AHT) before and during the COVID-19 pandemic.Design, Setting, and Participants: Retrospective, multicenter, repeated cross-sectional study, conducted January 1, 2016, through April 30, 2022, with data from tertiary care children’s hospitals and contributors to the Pediatric Health Information System. Data were obtained for 2380 hospitalizations of children younger than 5 years with International Classification of Diseases, Tenth Revision, Clinical Modification codes for both abuse and head trauma.Main Outcomes and Measures: Monthly hospitalizations were analyzed using interrupted time-series analysis. Hospitalization severity (eg, intensive care unit stay) and clinical characteristics (subdural hemorrhages and retinal hemorrhages) were compared before and after the start of the pandemic.Results: We identified 2380 hospitalizations due to AHT (median age, 140 [IQR, 75.0-325.5] days) from 45 hospitals. The mean (SD) monthly incidence of AHT was 34.3 (5.8) before the COVID-19 pandemic compared with 25.6 (4.2) during COVID-19 (a 25.4% decrease). When the pre–COVID-19 and during COVID-19 periods were compared, there were no significant differences in severity or clinical characteristics. On interrupted time-series analysis, there was a significant decrease in the number of monthly hospitalizations (−8.1; 95% CI, −12.41 to −3.72; P < .001) in the first month of the pandemic. In the subgroup of children younger than 1 year, there was a significant decrease in monthly hospitalizations at the onset of the pandemic (−8.2; 95% CI, −12.02 to −4.43; P < .001) followed by a significant temporal increase across the COVID-19 period (P = .01).Conclusions and Relevance: The findings of this cross-sectional study suggest there was a significant decrease in monthly hospitalizations for AHT following the start of the pandemic in March 2020. Although there was no corresponding increase in hospitalization severity, the decrease during the pandemic may have been transient, as monthly hospitalizations for children younger than 1 year increased significantly over time during COVID-19, after the initial decrease.


  • Cholecystitis and Gallstone Disease

    by Nathan Maassel, David H. Stitelman

  • Engineering alginate microparticles for optimized accumulation in fetal rat myelomeningocele

    by Mollie R. Freedman-Weiss, Douglas Wu, Nathan Maassel, Sarah J. Ullrich, Samantha L. Ahle, Katherine Roberts, James S. Farrelly, Gina Buzzelli, W. Mark Saltzman, David H. Stitelman


  • Intra-amniotic Injection of Poly(lactic-co-glycolic Acid) Microparticles Loaded with Growth Factor: Effect on Tissue Coverage and Cellular Apoptosis in the Rat Model of Myelomeningocele

    by Nathan L Maassel, Douglas H Bs Wu, Nicholas K Yung, Tory Bauer-Pisani, Mary Bs Elizabeth Guerra, Sarah J Ullrich, W Mark Saltzman, David H Md Stitelman

    Export BACKGROUND: Myelomeningocele (MMC) is a devastating congenital neurologic disorder that can lead to lifelong morbidity and has limited treatment options. This study investigates the use of poly(lactic-co-glycolic acid) (PLGA) microparticles (MPs) loaded with fibroblast growth factor (FGF) as a platform for in utero treatment of MMC. STUDY DESIGN: Intra-amniotic injections of PLGA MPs were performed on gestational day 17 (E17) in all-trans retinoic acid-induced MMC rat dams. MPs loaded with fluorescent dye (DiO) were evaluated 3 hours after injection to determine incidence of binding to the MMC defect. Fetuses were then treated with PBS or PLGA particles loaded with DiO, bovine serum albumin, or FGF and evaluated at term (E21). Fetuses with MMC defects were evaluated for gross and histologic evidence of soft tissue coverage. The effect of PLGA-FGF treatment on spinal cord cell death was evaluated using an in situ cell death kit. RESULTS: PLGA-DiO MPs had a binding incidence of 86% and 94% 3 hours after injection at E17 for doses of 0.1 mg and 1.2 mg, respectively. Incidence of soft tissue coverage at term was 19% (4 of 21), 22% (2 of 9), and 83% (5 of 6) for PLGA-DiO, PLGA-BSA, and PLGA-FGF, respectively. At E21, the percentage of spinal cord cells positive for in situ cell death was significantly higher in MMC controls compared with wild-type controls or MMC pups treated with PLGA-FGF. CONCLUSION: PLGA MPs are an innovative minimally invasive platform for induction of soft tissue coverage in the rat model of MMC and may reduce cellular apoptosis.


  • Open Access

    Firework-related injuries treated at emergency departments in the United States during the COVID-19 pandemic in 2020 compared to 2018–2019

    by Nathan Maassel, Abbie Saccary, Daniel Solomon, David Stitelman, Yunshan Xu, Fangyong Li, Emily Christison-Lagay, James Dodington

    Background: Despite a national decrease in emergency department visits in the United States during the first 10 months of the pandemic, preliminary Consumer Product Safety Commission data indicate increased firework-related injuries. We hypothesized an increase in firework-related injuries during 2020 compared to years prior related to a corresponding increase in consumer firework sales. Methods: The National Electronic Injury Surveillance System (NEISS) was queried from 2018 to 2020 for cases with product codes 1313 (firework injury) and narratives containing “fireworks”. Population-based national estimates were calculated using US Census data, then compared across the three years of study inclusion. Patient demographic and available injury information was also tracked and compared across the three years. Firework sales data obtained from the American Pyrotechnics Association were determined for the same time period to examine trends in consumption. Results: There were 935 firework-related injuries reported to the NEISS from 2018 to 2020, 47% of which occurred during 2020. National estimates for monthly injuries per million were 1.6 times greater in 2020 compared to 2019 (p < 0.0001) with no difference between 2018 and 2019 (p = 0.38). The same results were found when the month of July was excluded. Firework consumption in 2020 was 1.5 times greater than 2019 or 2018, with a 55% increase in consumer fireworks and 22% decrease in professional fireworks sales. Conclusions: Firework-related injures saw a substantial increase in 2020 compared to the two years prior, corroborated by a proportional increase in consumer firework sales. Increased incidence of firework-related injuries was detected even with the exclusion of the month of July, suggesting that the COVID-19 pandemic may have impacted firework epidemiology more broadly than US Independence Day celebrations.


  • Laparoscopy is increasingly used for pediatric inguinal hernia repair

    by Matthew P. Shaughnessy, Nathan L. Maassel, Nicholas Yung, Daniel G. Solomon, Robert A. Cowles


  • Institutional Variation in Gastrostomy Tube Placement After Duodenal Atresia Repair in Children With Trisomy 21

    by Nathan L. Maassel, Mary Elizabeth Guerra, Daniel G. Solomon, David H. Stitelman

    Objectives: To compare institutional practice patterns for gastrostomy tube placement in neonates with duodenal atresia (DA) and trisomy 21.Methods: A retrospective review of the Pediatric Health Information System (PHIS) from 2015 to 2018 identified infants <10 days old with ICD‐10 diagnostic codes for DA and trisomy 21, in addition to procedure codes for an intestinal bypass or duodenoduodenostomy. This cohort was then queried for gastrostomy tube procedure codes and diagnostic codes for associated co‐morbidities.Results: Two hundred and nine infants were identified with DA, trisomy 21, and an intestinal bypass. Fifty‐seven (27%) underwent gastrostomy placement. Baseline characteristics of those with and without gastrostomy tubes were similar. Patients from 16 hospitals that placed no gastrostomy tubes (No‐G‐tube‐Hospitals) were compared to children from 30 hospitals that placed at least one gastrostomy tube (G‐tube‐Hospitals). Open atresia repairs occurred more frequently at G‐tube‐Hospitals, but patients were otherwise similar. There was no difference in readmission at 12 months for gastrostomy placement between children from No‐G‐tube‐Hospitals and those from G‐tube‐Hospitals that did not undergo gastrostomy during their index admission.Conclusions: One‐third of institutions in this study did not place gastrostomy tubes during index admissions for neonates with trisomy 21 and DA, yet this did not negatively impact the length of stay or incidence of subsequent gastrostomy placement as a result. Future research is needed to determine factors that predispose patients to failure without gastrostomy, as well as best practices for post‐operative management in these patients to reduce unnecessary tube placement.


  • Hospital Admissions for Abusive Head Trauma at Children’s Hospitals During COVID-19

    by Nathan L. Maassel, Andrea G. Asnes, John M. Leventhal, Daniel G. Solomon


  • Open Access

    Diffusion weighted imaging as a biomarker of retinoic acid induced myelomeningocele

    by Nathan Maassel, James Farrelly, Daniel Coman, Mollie Freedman-Weiss, Samantha Ahle, Sarah Ullrich, Nicholas Yung, Fahmeed Hyder, David Stitelman

    Neural tube defects are a common congenital anomaly involving incomplete closure of the spinal cord. Myelomeningocele (MMC) is a severe form in which there is complete exposure of neural tissue with a lack of skin, soft tissue, or bony covering to protect the spinal cord. The all-trans retinoic acid (ATRA) induced rat model of (MMC) is a reproducible, cost-effective means of studying this disease; however, there are limited modalities to objectively quantify disease severity, or potential benefits from experimental therapies. We sought to determine the feasibility of detecting differences between MMC and wild type (WT) rat fetuses using diffusion magnetic resonance imaging techniques (MRI). Rat dams were gavage-fed ATRA to produce MMC defects in fetuses, which were surgically delivered prior to term. Average diffusion coefficient (ADC) and fractional anisotropy (FA) maps were obtained for each fetus. Brain volumes and two anatomically defined brain length measurements (D1 and D2) were significantly decreased in MMC compared to WT. Mean ADC signal was significantly increased in MMC compared to WT, but no difference was found for FA signal. In summary, ADC and brain measurements were significantly different between WT and MMC rat fetuses. ADC could be a useful complementary imaging biomarker to current histopathologic analysis of MMC models, and potentially expedite therapeutic research for this disease.


  • Nanoparticles for delivery of agents to fetal lungs

    by Sarah J. Ullrich, Mollie Freedman-Weiss, Samantha Ahle, Hanna K. Mandl, Alexandra S. Piotrowski-Daspit, Katherine Roberts, Nicholas Yung, Nathan Maassel, Tory Bauer-Pisani, Adele S. Ricciardi, et al.